122 related articles for article (PubMed ID: 22425264)
1. Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology.
Gore ME; Bellmunt J; Eisen T; Escudier B; Mickisch G; Patard J; Porta C; Ravaud A; Schmidinger M; Schöffski P; Sternberg CN; Szczylik C; De Nigris E; Wheeler C; Kirpekar S
Eur J Cancer; 2012 May; 48(7):1038-47. PubMed ID: 22425264
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT).
Gore ME; Bellmunt J; Eisen T; Escudier B; Mickisch G; Patard J; Porta C; Ravaud A; Schmidinger M; Schöffski P; Sternberg CN; Szczylik C; Lewis S; Kirpekar S
Eur J Cancer; 2014 Dec; 50(18):3153-60. PubMed ID: 25442842
[TBL] [Abstract][Full Text] [Related]
3. A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options.
Bellmunt J; Eisen T; Szczylik C; Mulders P; Porta C
BJU Int; 2011 Apr; 107(8):1190-9. PubMed ID: 21078050
[TBL] [Abstract][Full Text] [Related]
4. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.
Halbert RJ; Figlin RA; Atkins MB; Bernal M; Hutson TE; Uzzo RG; Bukowski RM; Khan KD; Wood CG; Dubois RW
Cancer; 2006 Nov; 107(10):2375-83. PubMed ID: 17048248
[TBL] [Abstract][Full Text] [Related]
5. Metastatic renal cell carcinoma: many treatment options, one patient.
Rini BI
J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.
Franklin JR; Figlin R; Rauch J; Gitlitz B; Belldegrun A
Semin Urol Oncol; 1996 Nov; 14(4):230-6. PubMed ID: 8946623
[TBL] [Abstract][Full Text] [Related]
7. EORTC-GU group expert opinion on metastatic renal cell cancer.
de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
[TBL] [Abstract][Full Text] [Related]
8. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
Hanley D; Gorelick PB; Elliott WJ; Broder MS; Saver JL; Kidwell CS; Fagan SC; Wilson A; Lennihan L; Schwer WA; Rubenstein LZ; Crowell RM; Haines SJ; Lopez CC; Zorowitz R; Dubois RW
J Stroke Cerebrovasc Dis; 2004; 13(5):196-207. PubMed ID: 17903976
[TBL] [Abstract][Full Text] [Related]
9. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
Wood CG
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
11. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma.
Margulis V; Master VA; Cost NG; Leibovich BC; Joniau S; Kuczyk M; Mulders PF; Kirkali Z; Wirth MP; Hirao Y; Rawal S; Chong TW; Wood CG
Eur Urol; 2011 Oct; 60(4):673-83. PubMed ID: 21752533
[TBL] [Abstract][Full Text] [Related]
12. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
[TBL] [Abstract][Full Text] [Related]
13. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
[TBL] [Abstract][Full Text] [Related]
14. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
Belldegrun AS; Klatte T; Shuch B; LaRochelle JC; Miller DC; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Dekernion JB; Pantuck AJ
Cancer; 2008 Nov; 113(9):2457-63. PubMed ID: 18823034
[TBL] [Abstract][Full Text] [Related]
15. The role of adjuvant therapy in non-metastatic RCC.
Bleumer I; de Mulder PH; Mulders PF
Can J Urol; 2006 Apr; 13 Suppl 2():57-62. PubMed ID: 16672131
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
Figlin R; Gitlitz B; Franklin J; Dorey F; Moldawer N; Rausch J; deKernion J; Belldegrun A
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant and neoadjuvant therapy in renal cell carcinoma.
Jonasch E; Tannir NM
Cancer J; 2008; 14(5):315-9. PubMed ID: 18836336
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma in children and adolescents.
Spreafico F; Collini P; Terenziani M; Marchianò A; Piva L
Expert Rev Anticancer Ther; 2010 Dec; 10(12):1967-78. PubMed ID: 21110762
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an information system for kidney transplantation in adult and pediatric recipients using the RAND/UCLA Appropriateness Method.
Santori G; Fontana I; Valente R; Ghirelli R; Valente U
Transplant Proc; 2008; 40(6):1844-6. PubMed ID: 18675066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
